Literature DB >> 6344991

Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.

C M Haskell, F Buchegger, M Schreyer, S Carrel, J P Mach.   

Abstract

As part of an ongoing effort to improve the technique of immunoscintigraphy for the detection of human carcinomas with radiolabeled monoclonal antibodies (MABs) to carcinoembryonic antigen (CEA), we have developed a series of MABs to CEA and have studied the effects of low- and physiological molarity buffers on their CEA binding and affinity, as well as their cross-reactivity with granulocyte glycoprotein(s). These in vitro results in different buffer systems were then correlated with the use of these MABs to CEA in the detection of human colon carcinoma grafts in nude mice. Our results show that the binding of CEA by some MABs is influenced by ionic strength and that this may be an important factor in their successful use for the immunolocalization of carcinomas in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344991

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Antibody transport and internalization into tumours.

Authors:  S Matzku; G Moldenhauer; H Kalthoff; S Canevari; M Colnaghi; J Schuhmacher; H Bihl
Journal:  Br J Cancer Suppl       Date:  1990-07

2.  A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.

Authors:  Nabil Mohie Abdel-Hamid; M M Abouzied; M H Nazmy; M A Fawzy; A S Gerges
Journal:  Tumour Biol       Date:  2015-09-19

3.  Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

Authors:  F Buchegger; C Pfister; K Fournier; F Prevel; M Schreyer; S Carrel; J P Mach
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 4.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Site-related differences in the localization of the monoclonal antibody OX7 in SL2 and SL1 lymphomas.

Authors:  H Sands; P L Jones; W P Neacy; S A Shah; B M Gallagher
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium.

Authors:  D Buchsbaum; B Randall; D Hanna; R Chandler; M Loken; E Johnson
Journal:  Eur J Nucl Med       Date:  1985

7.  Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.

Authors:  M V Pimm; N C Armitage; A C Perkins; W Smith; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma. A phase I study.

Authors:  M S Huberman; J J Lokich; T Hill; A Kaldany; A Kassis; T Price; C Moore; S Davis; P Kasulis; A P Monaco
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.

Authors:  B Delaloye; A Bischof-Delaloye; F Buchegger; V von Fliedner; J P Grob; J C Volant; J Pettavel; J P Mach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 10.  Intratumour factors influencing the access of antibody to tumour cells.

Authors:  L M Cobb
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.